154 related articles for article (PubMed ID: 29562286)
1. Health-industry linkages for local health: reframing policies for African health system strengthening.
Mackintosh M; Mugwagwa J; Banda G; Tibandebage P; Tunguhole J; Wangwe S; Karimi Njeru M
Health Policy Plan; 2018 May; 33(4):602-610. PubMed ID: 29562286
[TBL] [Abstract][Full Text] [Related]
2. Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias' in access to imported medicines in Tanzania and its policy implications.
Mujinja PG; Mackintosh M; Justin-Temu M; Wuyts M
Global Health; 2014 Mar; 10():12. PubMed ID: 24612518
[TBL] [Abstract][Full Text] [Related]
3. Rethinking health sector procurement as developmental linkages in East Africa.
Mackintosh M; Tibandebage P; Karimi Njeru M; Kariuki Kungu J; Israel C; Mujinja PGM
Soc Sci Med; 2018 Mar; 200():182-189. PubMed ID: 29421465
[TBL] [Abstract][Full Text] [Related]
4. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
Morgan S; McMahon M; Greyson D
Health Policy; 2008 Aug; 87(2):133-45. PubMed ID: 18295927
[TBL] [Abstract][Full Text] [Related]
5. On the margins of aid orthodoxy: the Brazil-Mozambique collaboration to produce essential medicines in Africa.
Russo G; de Oliveira L; Shankland A; Sitoe T
Global Health; 2014 Sep; 10():70. PubMed ID: 25252701
[TBL] [Abstract][Full Text] [Related]
6. An improved maize marketing system for African countries: the case of Zimbabwe.
Child B; Muir K; Blackie M
Food Policy; 1985 Nov; 10(4):365-73. PubMed ID: 12280292
[TBL] [Abstract][Full Text] [Related]
7. Corporate social responsibility to improve access to medicines: the case of Brazil.
Thorsteinsdóttir H; Ovtcharenko N; Kohler JC
Global Health; 2017 Feb; 13(1):10. PubMed ID: 28222793
[TBL] [Abstract][Full Text] [Related]
8. Improving access to medicines in poor countries: the role of universities.
Chokshi DA
PLoS Med; 2006 Apr; 3(6):e136. PubMed ID: 16608382
[TBL] [Abstract][Full Text] [Related]
9. Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence.
Rockers PC; Wirtz VJ; Umeh CA; Swamy PM; Laing RO
Health Aff (Millwood); 2017 Apr; 36(4):706-713. PubMed ID: 28373337
[TBL] [Abstract][Full Text] [Related]
10. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
11. Implications of national tax policy on local pharmaceutical production in a southwestern state nigeria - qualitative research for the intersection of national pharmaceutical policy on health systems development.
Obembe TA; Adenipekun AB; Morakinyo OM; Odebunmi KO
BMC Health Serv Res; 2022 Feb; 22(1):264. PubMed ID: 35220971
[TBL] [Abstract][Full Text] [Related]
12. Providing affordable essential medicines to African households: the missing policies and institutions for price containment.
Tetteh Ek
Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug use in Bangladesh: policy versus practice.
Islam MS
Indian J Med Ethics; 2008; 5(1):24-5. PubMed ID: 18630250
[TBL] [Abstract][Full Text] [Related]
14. The performance and problems of the Turkish pharmaceutical industry: is there a need to develop a national drug policy?
Kisa A
J Med Syst; 2001 Oct; 25(5):309-18. PubMed ID: 11508904
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceuticals--strategic considerations in health reforms in Pakistan.
Nishtar S
J Pak Med Assoc; 2006 Dec; 56(12 Suppl 4):S100-11. PubMed ID: 17595837
[TBL] [Abstract][Full Text] [Related]
16. Implementation of medicines pricing policies in sub-Saharan Africa: systematic review.
Koduah A; Baatiema L; de Chavez AC; Danso-Appiah A; Kretchy IA; Agyepong IA; King N; Ensor T; Mirzoev T
Syst Rev; 2022 Dec; 11(1):257. PubMed ID: 36457058
[TBL] [Abstract][Full Text] [Related]
17. The UNESCO Bioethics Declaration 'social responsibility' principle and cost-effectiveness price evaluations for essential medicines.
Faunce TA
Monash Bioeth Rev; 2005 Jul; 24(3):10-9. PubMed ID: 16302317
[TBL] [Abstract][Full Text] [Related]
18. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.
Kotwani A
BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985
[TBL] [Abstract][Full Text] [Related]
19. Reprivatizing pharmaceutical supplies in Africa.
Turshen M
J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
